There are 2 types of hypothyroid, primary and congenital. Secondary hypothyroidism will affect all body systems. The onset is usually over months or years. The lower level of TH (thyroid hormone) is produced by the thyroid gland. Causes of secondary hypothyroidism can include insufficient stimulation of the normal gland, causing TSH (thyroid stimulating hormone) deficiency. There can also be a peripheral resistance to TH.
Clinical manifestations of hypothyroidism can include: confusion, syncope, slowed speech and thinking, memory loss, lethargy, headaches, hearing loss, night blindness, slow, clumsy movements, enlarged pituitary thyrotropes, decreased libido, dyspnea, myxedematous changes in respiratory muscles leading to hypoventilation and carbon dioxide retention, water retention, weight gain, slow movement, dry, flaky skin, dry, brittle, hair, and nnyxedema among other symptoms.
Treatment is based on clinical symptoms, and a decrease in serum T4 and free T4 nearly always is present. TSH concentration increases from loss of negative feedback from thyroid hormone. Hormone replacement therapy is the treatment of choice for hypothyroidism. It is available as a synthetic hormone (levothyroxine or liothyronine).
Hyperparathyroidism is a greater than normal secretion of parathyroid hormone (PTH). The reasons for primary hyperparathyroiclism are classified as either primary or secondary. Primary is a greater than normal secretion of PTH by one or more of the parathyroid glands. The normal feedback mechanisms, such as elevated serum levels of ionized calcium, fail to inhibit PTH secretion by the parathyroid gland. Secondary hyperparathyroidisnn occurs when there is an increase in PTH due to a chronic disease state, including chronic renal failure.
Clinical manifestations are excessive osteoclastic and osteocytic activity, resulting in bone resorption. Outward signs are pathologic fractures, kyphosis of the dorsal spine, and compression fractures of the vertebral bodies. Other symptoms are a greater than 6-month history of hypercalcennia, including kidney stones, hypophosphatemia, hyperchloremia, and increased urinary calcium levels. Treatment includes lowering of severely elevated calcium levels, increasing urinary calcium excretion with diuretics, and long-term management of hypercalcemia by use of drugs that decrease resorptIon of calcium from bone.
Groups of disease with glucose intolerance in common are often called Diabetes Mellitus. There are 2 recognized forms: one that affects obese individuals and another, which is found mainly among the young. The diagnosis of diabetes is based on one of the following: 1- fasting plasma glucose level > 126 mg/dL, 2- glucose value in the 2 hour sample (2hPG) of the standard oral glucose tolerance test (OGTT) of > 200 nng/dL, 3- a plasma glucose level >200 mg/dL anytime during the day, often with the classics symptoms of polydipsia, polyphagia, and polyuria. In Type I, the beta-cells fail, or the cause is idiopathic. In Type II, cells become insulin resistant with Inadequate insulin secretion. Symptoms of Type I are polydipsia, polyuria, polyphagia, weight loss, and fatigue, among others. Symptoms of Type II are often nonspecific. The individual is often over 30, over weight, dyslipidennic, hyperinsulinemic, and hypertensive. The onset tends to be slow and insidious. Other symptoms can include fatigue, pruritus, recurrent Infections, visual changes, or paresthesias.
Treatment for Type I includes control of blood sugars through frequent blood sugar checks and adjusting insulin, diet, and exercise to keep the blood sugars between 70 and 120. Treatment for Type II begins with weight loss, dietary management, and if need be, either oral or insulin medication. In Type II, exercise, in addition to the establishment and maintenance of nutritional therapy, can bring the disease under control.
Cushing Syndrome or Cushing Disease refers to chronic hypercortisolism (excessive levels of circulating cortisol). The usual cause is ectopic ACTH-secretIng tumors, or adrenal-secreting tumors. Signs and symptoms are thinning of scalp hair, faclal flush, moon face, purple striae on the abdomen, truncal obesity, thin extremities, easy bruising, and increased body and facial hair. Treatment is specific for the cause of hypercorticoadrenalism and includes medication, radiation, and surgery.